Literature DB >> 24275955

Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.

Andrew J Swift1, Smitha Rajaram, Michael J Campbell, Judith Hurdman, Steve Thomas, Dave Capener, Charlie Elliot, Robin Condliffe, Jim M Wild, David G Kiely.   

Abstract

BACKGROUND: There are limited data on the prognostic value of cardiovascular magnetic resonance measurements in idiopathic pulmonary arterial hypertension, with no studies investigating the impact of correction of cardiovascular magnetic resonance indices for age and sex on prognostic value. METHODS AND
RESULTS: Consecutive patients with idiopathic pulmonary arterial hypertension underwent cardiovascular magnetic resonance imaging at 1.5T. Steady-state free precession cardiac volumes and mass measurements were corrected for age, sex, and body surface area according to reference data and prognostic significance assessed. A total of 80 patients with idiopathic pulmonary arterial hypertension were identified, and 23 patients died during the mean follow-up of 32±14 months. Corrected for age, sex, and body surface area, right ventricular end-systolic volume (P=0.004) strongly predicted mortality, independent of World Health Organization functional class, mean right atrial pressure, cardiac index, and mixed venous oxygen saturations.
CONCLUSIONS: Consideration should be given to correcting cardiovascular magnetic resonance measures for age, sex, and body surface area, particularly given the changing demographics of patients with idiopathic pulmonary arterial hypertension. Corrected right ventricular end-systolic volume is a strong prognostic marker in idiopathic pulmonary arterial hypertension, independent of invasively derived measurements, mean right atrial pressure cardiac index, and mixed venous oxygen saturations.

Entities:  

Keywords:  heart ventricles; hypertension, pulmonary; magnetic resonance imaging; prognosis

Mesh:

Year:  2013        PMID: 24275955     DOI: 10.1161/CIRCIMAGING.113.000338

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  37 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 2.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

Review 3.  Assessment of right ventricular function in pulmonary hypertension.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

4.  Imaging right ventricular function to predict outcome in pulmonary arterial hypertension.

Authors:  Melanie J Brewis; Alessandro Bellofiore; Rebecca R Vanderpool; Naomi C Chesler; Martin K Johnson; Robert Naeije; Andrew J Peacock
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

5.  Sex-specific cardiopulmonary exercise testing parameters as predictors in patients with idiopathic pulmonary arterial hypertension.

Authors:  Ping Yuan; Hui-Juan Ni; Tian-Xiang Chen; Bigyan Pudasaini; Rong Jiang; Hui Liu; Qin-Hua Zhao; Lan Wang; Su-Gang Gong; Jin-Ming Liu
Journal:  Hypertens Res       Date:  2017-06-01       Impact factor: 3.872

6.  Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Authors:  Catherine E Simpson; Rachel L Damico; Todd M Kolb; Stephen C Mathai; Rubina M Khair; Takahiro Sato; Khalil Bourji; Ryan J Tedford; Stefan L Zimmerman; Paul M Hassoun
Journal:  Eur Respir J       Date:  2019-04-04       Impact factor: 16.671

7.  The role of nuclear imaging in pulmonary hypertension.

Authors:  H Ohira; R S Beanlands; R A Davies; L Mielniczuk
Journal:  J Nucl Cardiol       Date:  2014-08-27       Impact factor: 5.952

8.  Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.

Authors:  Hiroyuki Kamide; Shingo Kato; Keigo Hayakawa; Kazuki Fukui; Hideya Kitamura; Takashi Ogura; Tae Iwasawa; Kazuo Kimura; Kouichi Tamura; Daisuke Utsunomiya
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-28       Impact factor: 2.357

9.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

10.  Does Late Gadolinium Enhancement still have Value? Right Ventricular Internal Mechanical Work, Ea/Emax and Late Gadolinium Enhancement as Prognostic Markers in Patients with Advanced Pulmonary Hypertension via Cardiac MRI.

Authors:  Amr Ei Abouelnour; Mark Doyle; Diane V Thompson; June Yamrozik; Ronald B Williams; Moneal B Shah; Siva Kr Soma; Srinivas Murali; Raymond L Benza; Robert Ww Biederman
Journal:  Cardiol Res Cardiovasc Med       Date:  2017-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.